19 July 2012
Systemic lupus erythematosus with a non functioning pituitary macroadenoma
Ummi Nadira, Rizna Abdul Cader, Norella C.T Kong, Rozita Mohd, Halim A. GaforDOI: 10.12659/AJCR.883248
Am J Case Rep 2012; 13:160-162
Abstract
Background: Malignancies are more common in patients with systemic lupus erythematosus (SLE) than the general population. SLE patients are recognized to have higher prolactin levels. However, there are very few reported cases of SLE with pituitary adenomas.
Case Report: We report the second case of a pituitary adenoma in a patient with underlying SLE. A 51 year old lady presented with blurred vision and magnetic resonance imaging of the brain demonstrated a pituitary macroadenoma with mildly elevated serum prolactin levels. The diagnosis of a non functioning pituitary macroadenoma was confirmed histologically. The diagnosis of SLE was made on the basis of thrombocytopenia, antinuclear antibodies, anti double stranded DNA antibodies and lupus nephritis (confirmed on renal biopsy). The patient initially received medical therapy with carbegoline, followed by transsphenoidal neurosurgery for the pituitary macroadenoma. SLE with lupus nephritis was treated with steroids and low dose intravenous cyclophosphamide.
Conclusions: Hyperprolactinaemia is prevalent in twenty to thirty percent of SLE patients but it is rarely due to a prolactinoma. The source of excessive circulating prolactin in SLE patients has not been fully determined.
Keywords: pituitary macroadenoma, Systemic lupus erythematosus, prolactin
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945921
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946916
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946269
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948017
Most Viewed Current Articles
21 Jun 2024 : Case report
93,397
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,131
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
27,838
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,970
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030